Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02951143 · ClinicalTrials.gov registry record · NA
Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 305
- Enrollment target
NCT02951143 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 305 participants.
The verdict
NCT02951143, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
Study Summary
Tobacco regulatory policies can have unanticipated consequences; therefore, methods that would permit prospective estimates of the effects of potential tobacco regulations are necessary for the development of tobacco regulatory science. The goal of this project is to experimentally assess how smokers purchase and consume reduced-nicotine cigarettes. In experiment 1, we will investigate how purchasing/consuming reduced-nicotine cigarettes is related to nicotine content and absorption. In experiment 2, we will investigate how purchasing/consuming changes when other nicotine products are available in an experimental marketplace setting. The proposed projects can directly inform tobacco regulation by providing estimates of the real-world effects of novel policies.
Interventions
- DRUG SPECTRUM cigarettes
- DRUG SPECTRUM cigarettes between
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02951143
The ClinicalTrials.gov registry entry for NCT02951143 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SPECTRUM cigarettes is the first listed.
NCT02951143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02951143 about?
NCT02951143 is a clinical study titled "Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace". Tobacco regulatory policies can have unanticipated consequences; therefore, methods that would permit prospective estimates of the effects of potential tobacco regulations are necessary for the development of tobacco regulatory science. The goal of this project is to experimentally assess how smoker...
What is the current status of trial NCT02951143?
This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2017-01. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02951143?
The interventions under investigation include: SPECTRUM cigarettes (DRUG), SPECTRUM cigarettes between (DRUG).
Who is sponsoring clinical trial NCT02951143?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.